Cours Summit Therapeutics plc London S.E.
Actions
GB00BN40HZ01
Recherche biotechnologique et médicale
CA 2024 * | - | CA 2025 * | - | Capitalisation | 2,39 Md 3,03 Md 2,78 Md |
---|---|---|---|---|---|
Résultat net 2024 * | - | Résultat net 2025 * | - | VE / CA 2024 * | - |
Trésorerie nette 2024 * | - 0 0 | Trésorerie nette 2025 * | - 0 0 | VE / CA 2025 * | - |
PER 2024 * |
-
| PER 2025 * |
-
| Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 11,86% |
Dernier transcript sur Summit Therapeutics plc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 11/11/20 |
Robert Duggan
CEO | Chief Executive Officer | 79 | 01/12/19 |
Director of Finance/CFO | 46 | 01/12/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Robert Duggan
CEO | Chief Executive Officer | 79 | 01/12/19 |
Robert Booth
BRD | Director/Board Member | 70 | 28/09/22 |
Director of Finance/CFO | 46 | 01/12/19 |
Varia. 1 janv. | Capi. | |
---|---|---|
+10,79% | 116 Md | |
+11,65% | 106 Md | |
-6,20% | 23,89 Md | |
-3,58% | 21,58 Md | |
-11,30% | 18,96 Md | |
-40,50% | 16,96 Md | |
-13,41% | 16,33 Md | |
+6,64% | 14,14 Md | |
+31,84% | 12,02 Md |